BackMedical Cannabis Payment Solutions Overview

Medical Cannabis Payment Solutions EBIT

Track Medical Cannabis Payment Solutions's EBIT ($-28K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$5.48K
↑ 53.81% YoY

As of Mar 31, 2023

Annual EBIT (TTM)

-$27.72K
↑ 98.09% YoY

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Medical Cannabis Payment Solutions (REFG) FAQ

As of the most recent data (March 2023), REFG shows a EBIT of $-28K. That compares with $-1.5M in the prior-year period — up 98.1% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REFG's EBIT is now $-28K (was $-1.5M) — a 98.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Medical Cannabis Payment Solutions is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. Medical Cannabis Payment Solutions is at $-28K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how REFG stacks up against individual peers as well.

Tracking REFG's ebit over time shows whether Medical Cannabis Payment Solutions is scaling, shrinking, or reshaping that part of the business. The current reading is $-28K That compares with $-1.5M in the prior-year period — up 98.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Medical Cannabis Payment Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-28K) with ownership activity and broader fundamentals.